Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (9666)	4/17/1999 10:40:00 AM
From: aknahow	Respond to of 17367

You said, "Observation 1> I believe every look at the data causes a "penalty" in proving a positive result." While I am not 100% sure what you mean, I think this is wide of the mark.<g> More logical from a cost and need basis. XOMA has already been told they can stop when they hit the pre established level and also been told that they stop in any event if they ad more and get closer. (The famous Curley Jack post). There are no safety concerns, it's a mater of why meet this week when we will be meting next week. or month to wrap up the trial. The lack of cash explains why they don't or can't move on other ideas. We do not know if there are no milestones, but even believing as I do, that there are none, XOMA cut a deal that IMO was very good. Bob, I realize you think it's just the Science, but I think the price of the stock is also important and I will bet you management agrees with me not with you. Each time they have to finance or negotiate with potential partners a robust price would be a plus. Biotechs in general must in the age of the Internet, wait for an appropriate conference to release data. We must wait till July for complete psoriasis data. Eventually the biotech industry must realize that investors cannot be expected to provide funding with the length and risk of trials and be kept in some sort of subordinate position for essential information. "Put your money up now, while many others know the details, and we will tell you about side effects and the results in two months." My solution? An appropriate Internet forum for Scientist. They can read can't they? Some sort of web site for each of the groups already exist. Papers could be published there first. Conferences still could be held, but everyone would recognize that in todays world waiting and holding data makes no sense and just further complicated and lessens investors desires to consider this industry.